chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial symptoms of blurry vision, dry sweats, loss of limb right slide function, and unable to speak at 4:00pm on 5/25/21. I was found down on the ground at work and brought to hospital at 4:15pm on 5/25/21. I had difficulty with following commands, unable to move the right side of face and entire right side of my body. Also had expressive aphasia and dysarthria.  I was taken to the operating room where they found a clot in the left side of my brain (LM2 cutoff) via internal carotid artery. TPA was administered and a catheter was inserted via my femoral artery to remove the clot from the left side of my brain. There was apparent loss of grey matter around the area of the clot. They found a larger clot within the left internal carotid artery.  Left-side carotid endarterectomy with use of patch graft was attempted on the morning of 5/26/21 where they removed a 2 cm by 0.5 cm clot. The patch graft procedure failed, and my left internal carotid artery could not be repaired due to the artery having poor tissue quality. After 10 hours in the operating room for a somewhat routine procedure that should have taken 2 hours, they had to sacrifice my left internal carotid artery and rely on the remaining arteries to supply blood/oxygen to my brain.   After I awoke the next day, they confirmed occlusion /sacrifice of the Left cervical ICA origin with no persistent embolic source (cephalad contrast column in ICA) and robust collateral circulation via the PCOM and ACOM. The clot was sent to the pathologist and sections show an organizing hemorrhage/thrombus dissecting between layers of an arterial wall with EVG positive elastin fibers on both sides of the dissection. Adjacent to the intramural hemorrhage/thrombus vascular wall architecture consists of anuclear fibrous or hyalinized eosinophilia rather than the laminated concentric layers of myocytes expected in a tunica media. There is also evidence of atherosclerotic plaque with cholesterol crystal cleft spaces in a faintly basophilic anuclear matrix, intramural foamy vacuolated lipid bearing cells, myointimal spindle cells, and dystrophic calcifications. An adjacent thrombus shows early organization with infiltrating fibroblasts. All follow up blood tests, Ehlers Danlos genetic test, cancer screening, blood clot screening, heart monitoring daily for 2 months were negative. This is being labeled as a cryptogenic stroke. Occurred approximately 9 weeks after second vaccine dose.
Chest pain. Started with body aches and Chest pain, but now only with chest pain and tightness.
I got more sores on my legs, especially on my left leg; my throat started hurting; my mouth started hurting; I had a sore on my leg because of being old. Immediately after shot, it doubled; A spontaneous report was received from a consumer concerning a 71-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events sore on leg because of being old. immediately after shot, it doubled, got more sores on legs, especially on left leg, throat started hurting, mouth started hurting.  The patient's medical history included knee replacement. Concomitant medications reported were Lisinopril 20 mg once a day, Atenolol, Chlorthalidone, Amlodipine, Prazosin, Atorvastatin, Amitriptyline, Montelukast, Baclofen, Symbicort for unknown indication.  On 9 Feb 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: 031M20A) via unknown route for prophylaxis of COVID-19 infection.  On 9 Feb 2021, after  few hours of vaccine administration the patient experienced the events  sore on leg because of being old. immediately after shot, it doubled. On an unknown date, the patient experienced the events got more sores on legs, especially on left leg, throat started hurting, mouth started hurting.  No treatment reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, sore on leg because of being old, immediately after shot, it doubled,  got more sores on legs especially on left leg was resolving and throat started hurting was resolved, and mouth started hurting was unknown.
Not reported because of an adverse reaction.  Reported because the patient received a 1 mL dose instead of the intended 0.5 mL dose.  Patient tolerated the over-dosage while admitted in the ED per report.  Was discharged shortly after.
This spontaneous report was received from a medical assistant refers to a 24 year old female patient. On 10-JUL-2013, the patient was accidentally vaccinated with a dose of ZOSTAVAX (lot #, expiry not reported) instead of VARIVAX (Merck). No adverse effects reported. Additional information has been requested.
Papular rash began on lower legs and extended to upper back and shoulders (bilateral) with itching.
Extreme joint pain for several weeks; Water in the inner ear; Curvature of the penis; This is a spontaneous report received from a non-contactable nurse, (patient himself). A 62-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown, Expiration date was not reported), via an unspecified route of administration on an unspecified date (at the age of 62-years-old) as a dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, has the patient been tested for COVID-19 was reported as no. On an unspecified date, the patient experienced extreme joint pain for several weeks, water in the inner ear, curvature of the penis. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Patient received vitamin d, pain killers as treatment medications for the resulted events. The outcome of the events was not recovered.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Mom reports that pt was sweaty and nauseated within 5 minutes, post vax. Temperature 99.6F today and complaining of fatigue, sore throat, swollen lymph nodes and headache.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 64-year-old male patient received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown) and as dose 4 (booster), single (Batch/Lot number: unknown) for Covid-19 immunisation. The patient's relevant medical history was not reported. The patient took concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (15Jun2022) Positive, notes: Symptoms have returned, positive antigen test; (unspecified date) Unknown Results, notes: Indication: Treatment of COVID-19. Therapeutic measures were taken as a result of drug ineffective, Covid-19.- Clinical course: Other medication in two weeks: Yes. Anti viral details: Product: COVID 19 Treatment, Brand: Paxlovid. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Noticed small rash on right arm (shot was administered in left arm) it only hurt when in the shower otherwise didn?t notice it. Took a Benadryl just in case after seeing reaction. Woke up today and rash is almost gone. Doesn?t hurt to touch.
Pt developed red rash w/ itching and pain and swelling, pt reported said event 8 days after injection and went to doctor. Doctor stated it was due to contamination at injection site and gave cephalexin.
Dizziness presented 1hr post vaccination and resolved with rest. Headache presented with dizziness but persisted and still ongoing  despite tx of Tylenol and Ibuprofen. Arthralgia, diffuse, presented approximately 2030 night of vaccination and remains ongoing issue despite tx with above listed medications, heat, and rest. Abdominal pain, diarrhea, and nausea. Abdominal pain and diarrhea presented night of vaccination and nausea approximately 2000 the following night. No relief with zofran 8mg. Chills with documented MTemp 99.9°F. Fatigue and overall malaise.
experienced a headache; fever; This is a spontaneous report from a Pfizer-sponsored program. A contactable consumer (Patient) reported that. A male patient of an unspecified age received BNT162B2 (COMIRNATY; Formulation: Solution for injection, Batch/Lot Number: was not reported), via an unspecified route of administration, on 10Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced a headache and fever. Therapeutic measures were taken for events with Advil and Benadryl. The outcome of the event was unknown.  Information on the lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
Approximately one hour following influenza vaccination patient was found sitting upright in the elevator. 911 was called an ambulance came shortly thereafter. From what I could gather she fainted. She was sitting upright in the elevator holding her head and stating she received a flu shot earlier. I attempted to call the patient three times on different days at different times to find out more details about what happened after she was taken to the hospital, but the patient never picked up the phone or returned any of my calls.
Irregular vaginal bleeding potentially related to menstrual cycle. Mild lightheadedness due to blood loss. Bleeding has continued on/off for the last 29 days forcing the patient to seek treatment.
Patient was in clinic for her 12 month check-up and immunizations. Provider ordered a dose of MMR and a dose or Varicella, and ordered them separately per our organizations guidelines as we do not give MMRV until age 4 due to risk of febrile seizures. When nurse was drawing up vaccines, a dose of MMRV was mistakenly put into a box of varicella vaccine.  When nurse went to put the lot number into our computer database, the lot wasn't populating so she hand typed it in instead of stopping and checking with a colleague or making sure that the vaccination she had was the one that the provider ordered. She administered both the MMR and the MMRV. When she went back to her computer to double check them another nurse realized that she had given the MMRV instead of the Varicella that was ordered. The provider was immediately notified, and the provider along with writer informed the patient's mother who was here today with the patient. Advised on what to look for as far as symptoms that normally occur with vaccine administration and that symptoms may be more pronounced with a double dose. Gave mother the informational sheet on Tylenol and ibuprofen dosing, and our direct nurseline number should she have any further questions. Mother aware we are writing this VAERS report and following up with our organization's immunization team.
Patient started having severe chest pains late the evening of 12/12/21. I gave her tylenol with no relief and took her to the pediatric ER around 2am that morning after she was crying on the bathroom floor from the pain in her chest.
Patient c/o sadness and tiredness 3 hours after injection. Symptoms lasted approximately 3 days.
Low grade fever for 2 days after shots.  July 29, 2006 c/o legs hurt & trouble walking. July 30, 2006 couldn't walk or stand.  Mother gave Motrin. July 31, 2006 pt could walk and seemed to improve.  Tues Aug 1, 2006 couldn't walk & went to doctor.  Started on 2tsp Motrin q 6 h. Pt better today.  If does not improve will return to doctor for further tests.  DX:  TOXIC SYNOVITIS
felt like cold coming on; chills; malaise; headache same day as vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 66 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 22Mar2021 09:30 (Lot number: EP6955) at the age of 66 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "COVID-19" (unspecified if ongoing); "allergies" (unspecified if ongoing). Concomitant medication(s) included: HYDROXYCHLOROQUINE. The following information was reported: NASOPHARYNGITIS (non-serious) with onset 23Mar2021, outcome "recovered" (Mar2021), described as "felt like cold coming on"; HEADACHE (non-serious) with onset 22Mar2021, outcome "recovered" (Mar2021), described as "headache same day as vaccine"; CHILLS (non-serious) with onset 23Mar2021, outcome "recovered" (Mar2021), described as "chills"; MALAISE (non-serious) with onset 23Mar2021, outcome "recovered" (Mar2021), described as "malaise". Therapeutic measures were not taken as a result of nasopharyngitis, headache, chills, malaise.  Additional information: The patient was not pregnant at the time of vaccination. Concomitant medications also included an unspecified multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.    No follow-up attempts are possible. No further information is expected.
Information has been received from a health professional concerning a 74 year old female with allergies to acetaminophen (+) hydrocodone bitartrate (LORTAB) and acetaminophen (+) codeine phosphate (TYLENOL 3) who on 26-OCT-2005 was vaccinated intramuscular in the right deltoid with a dose of pneumococcal 23v polysaccharide vaccine.  Concomitant vaccines that day included the influenza vaccine (unspecified).  There was no illness at the time of vaccination.  On 26-OCT-2005 she had a severe local reaction on the right arm at or near the injection site of the pneumococcal 23v polysaccharide vaccine.  She had discomfort, bruising, inflammation and redness.  The outcome was unknown. Unspecified medial attention was sought.  No product quality complaint was involved.  Follow up information indicated that the patient returned to the office on 28-OCT-2005, she had felt arm discomfort on that day of injection.  Over the next 2 days, beginning on 28-OCT-2005, the patient had bruising and inflammation to the site and the surrounding area was red and hot with swelling.  No laboratory tests are performed and the patient recovered on 31-OCT-2005.  Additional information is not expected.
Extremely exhausted; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 16Apr2021 at 19:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to tuna (Fish allergy) and allergy to rosemary (herbal allergy). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valaciclovir hydrochloride (VALACYCLOVIR), dicycloverine (DICYCLOMINE) and ascorbic acid (VITAMIN C) and multi-vitamins (MANUFACTURER UNKNOWN); all for unknown indications from an unknown date and unknown if ongoing. On 16Apr2021 at 21:00, the patient was extremely exhausted and experienced nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event extremely exhausted and nausea was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
massive itching; There is resolutions till date its painfull itching sleep interupted.; red rashes all over body and face swollen/red rashes erruptions.; face swollen/worsen with swelling; This is a spontaneous report from a contactable consumer (patient). A 65-year-old male patient received he second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot Number: ER8731), via an unspecified route of administration at the age of 65-year-old at arm Left on 14Apr2021 14:30 at single dose for COVID-19 immunization. Medical history was reported as no illness ever before, Prior to vaccination, the patient wasn't diagnosed with COVID-19. Concomitant medications were not reported. There were no other medications the patient received within 2 weeks of vaccination. The patient previously received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EP7534) at the age of 65-year-old at left arm on 26Mar2021 01:15 PM for COVID-19 immunisation. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. Facility where the most recent COVID-19 vaccine was administered in pharmacy or drug store. Since the vaccination, the patient hasn't been tested for COVID-19. In 8 hours of receiving vaccin second shot on Friday (as reported) red rashes all over body and face swollen on 14Apr2021. Went to Urgent care on Saturday (as reported) the hospital on Sunday (as reported) as situation worsen with swelling and massive itching and red rashes erruptions on 17Apr2021 12:00. There was resolutions till date its painfull itching sleep interrupted on 17Apr2021 12:00, over two weeks now. The patient was hospitalized for one day for events. The adverse event result in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient received treatment (steroid intravenous then oral till date) for the adverse event. The outcome of events was not recovered.
Extreme fatigue (sleeping 20-22 hours per day).  In Jan. she started to throw up, on 1/19 she had a migraine symptom that was painful and affected her vision for 3 days, vomiting continued for 5 weeks, then fainting started and lasted for a week, extreme fatigue and underlying headache during all this time.  In end of April, headache stopped, but fatigue continued.  In Jan. patient had a CT scan, EKG and blood work, along with an ophthalmologist appt. In Feb. she got the 2nd dose of Gardasil (we didn't know what was wrong with her).  She had an upper GI in Feb.  In March she had an endoscope, ultra sound of all her organs, MRI, EEG and more blood work.  We are currently seeing a naturpath Dr. trying to "detox" her.  9/22/09 School medical records received DOS 12/14/08 to 2/17/09. Several visits. Patient tired, could not function, slept all day and night, thowing up several times a day. Dizzy, sweaty, feels she will pass out. Vision blurry, poor depth perception. Migraine headache.  9/22/09 PCP medical records received DOS 12/02/08 to 6/19/09. Assessment: Complex Migraines.  Patient presents with unexplained vision abnormality. Eye exam normal. Dizzy spells, headaches, vomiting, GERD, weight loss, syncope. Neurology consult - Complex Migraines - otherwise WNL.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 13-MAR-2017, the patient was vaccinated with incorrectly stored dose of M-M-R II (dose, frequency, route of administration were not reported, lot # M002418, expiration date 12-JAN-2018, status albumin: recombinant human albumin (rHA)). Concomitant medications were not reported. Administered vaccine experienced the temperature excursion of -14.4 Celsius degrees for 54 minutes. Data logger was involved. No adverse effects reported.    This is one of several reports received from the same reporter. Additional information is not expected, all information has already been obtained.; Sender's Comments: US-009507513-1611USA011831: US-009507513-1611USA004113: US-009507513-1705USA009742:
Loss of energy. Injection site inflammation. Injection site swelling. Injection site warmth. From initial information received on 01/oct/2003 from a health care professional regarding an adverse event occurring in the USA, it was reported that a four year old male patient received his fourth dose of DAPTACEL, lot number C1387AA, adminis. intra-muscularly in the left deltoid on 26/Sep/2003 at 3:15 PM. Two days later, the patient's arm "balloned" from the biceps to the forearm, was hot and tight. The area measured 6-7 inches long x 2-3 inches wide. According to the patient's mother, the child also had low energy for two days. The reaction at the injection site had gone down slightly by the third day and the patient was afebrile. The patient recovered from this event. The reporter of this case is the same reporter of case U1999-00295.
inceasing shortness of breath,  ending with echo cardiogram describing several malfunction valves not noted earlier
Information has been received from a healthcare worker referring to a patient of unknown age and gender. On 23-NOV-2015, the patient was inadvertently vaccinated with one expired dose of MMR II (lot # J014875, expiration date 21-NOV-2015, dose and route unknown). No adverse effects reported. No PQC was involved. Additional information has been requested.
Pt observed falling to the floor, sweating.O2 100% HR 59 118/79 BS 92 EKG 12 lead NSR HR 84 Regular
Feels different than normal; labored breathing, also while sleeping; Forehead feels warm; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels different than normal), DYSPNOEA (labored breathing, also while sleeping) and FEELING HOT (Forehead feels warm) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included Smoker (quit 25 years ago).    On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced FEELING ABNORMAL (Feels different than normal), DYSPNOEA (labored breathing, also while sleeping) and FEELING HOT (Forehead feels warm). At the time of the report, FEELING ABNORMAL (Feels different than normal), DYSPNOEA (labored breathing, also while sleeping) and FEELING HOT (Forehead feels warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment or concomitant medication was reported. Patient mentioned that he has stent.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Followup received and contains non-significant information.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Red area that is warm about 3 inches diameter at injection site and fever 101.9.
After H1N1 clinic @ preschool, it was discovered that vaccine given to the 3yr old children was for children 4yrs and older. No immediate reaction noted.
Heart palpitations tiredness heart suddend pain chest discomfort (feeling like cold icecube melting on upper chest) plan to visit walk in center Shortness of breath